184: Phase I Study of Bortezomib, (BTZ) followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL)
M. Alsina, T. Alekshun, C. McIsaac-Simonelli, M. Kharfan-Dabaja, W. Dalton, B. Djulbegovic, H. Fernandez, D.M. Sullivan, E. Ayala, T. Field, D. Garrett, W.E. Janssen, B. Maddox, L.E. Perez, D. KettnerVolume:
14
Year:
2008
Language:
english
DOI:
10.1016/j.bbmt.2007.12.193
File:
PDF, 52 KB
english, 2008
File converter
More search results
More benefits 
